Romness Paul A. 4
4 · OS Therapies Inc · Filed Dec 19, 2025
Insider Transaction Report
Form 4
OS Therapies IncOSTX
Romness Paul A.
DirectorPresident and CEO
Transactions
- Award
Stock options (right to buy)
2025-10-21+1,950,000→ 1,950,000 totalExercise: $1.80Exp: 2035-10-21→ Common Stock (1,950,000 underlying)
Holdings
- 2,473,000
Common Stock
Footnotes (1)
- [F1]On October 21, 2025, the reporting person was granted options to purchase 1,950,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date.